【24h】

Mo-99 PRODUCTION USING LEU

机译:MO-99 production u single U

获取原文

摘要

Molybdenum-99(~99Mo)is the most commonly used medical isotope in the world,with an estimated usage of 20-25 million procedures performed annually.Most is now produced by irradiating highly enriched uranium(HEU)targets.There is no domestic U.S.production of ~99Mo and the continuing use of HEU can present a threat to U.S.national security.The U.S.depends of foreign sources, principally Canada,for its medical needs.Other major producers are IRE(Belgium),Mallinckrodt (The Netherlands),and NTP(South Africa).The Global Threat Reduction Initiative(GTRI) Reactor Conversion Program is developing technology to allow producers to convert their operations from HEU to low enriched uranium(LEU).
机译:Molybdenum-99(〜99Mo)是世界上最常用的医疗同位素,估计每年进行20-2500万程序。现在辐照高度富集的铀(Heu)目标。没有国内生产〜99Mo和河谷的持续利用可能对建设性的威胁产生威胁。外国来源的互相依赖于加拿大的医疗需求。其他主要生产商是IRE(比利时),Mallinckrodt(荷兰),以及NTP(南非)。全球威胁减少倡议(GTRI)反应堆转换计划正在开发技术,以允许生产者将其从Huu转换为低富集的铀(Leu)的行动。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号